The Convergence of Forces

See into the future of the business of diabetes

Diabetic Investor has been a must-read resource for investors in the diabetes space for over 20 years. Our Special Report “The Convergence of Forces” gives you a comprehensive look at the trends that will shape the industry for years to come.

A blueprint to anyone bold enough

This is not your average report. No fluff. No bull. Just facts and actionable analysis from David Kliff, who has lived with Type 1 diabetes for over 20 years and is trusted by some of the most respected names in pharma, medtech and Wall Street.

Anticipate transformation

While others are caught off-guard, you’ll be ready. Advanced technology, new therapy options, AI, digital health. With each transformation, those from the old way of doing things will be desperately trying to adapt.

Trusted for over 20 years

The Diabetic Investor brings a historical perspective that can’t be matched by other analysts, and it shows.
• We made the call to buy Dexcom when it was below $60
• We predicted the failure of Exubera when everyone else called it a blockbuster
• We were first to report BGM devices would be marketed as consumer devices – not medical devices

Reviews from our readers

I have made good investments based on publications of The Diabetes Investor. Great perspective on the diabetes industry. Thank you Mr. Kliff!

Healthcare Investor

Love it or not.... The Diabetic Investor is a well-connected and reliable source for the diabetes industry. The honesty can be brutal, but it is honest and based on fact. It is a must read for anyone who is serious about knowing the scoop on diabetes companies.

Former Executive
Sanofi, Insulet and Johnson&Johnson

I've been reading 'Diabetic Investor' for many years, and I never miss it. It gives me a different perspective, more often a more realistic perspective on the business of diabetes. For me it has become a 'must read' as the business of diabetes has exploded.

Irl Hirsch
MD

I love Diabetic Investor. I have always found two things. One, David always seems to hear the rumors, and read the tea leaves...early. Two, David provides the analysis to help understand those tea leaves. It's more than just what happened....but WHY.

MedTech
CEO

I relied on Diabetic Investor to provide an unbiased and unfiltered view of the world of diabetes.

Terry Gregg
Retired Diabetes Executive

Get the Report

Enter your information below, and we’ll be in touch shortly with more information.